Precision Diagnostics and the ADC Revolution
Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics
Objective:
Revise to directly reflect the source material's focus on ADCs and diagnostics.
Key Findings:
- Remove unsupported implications about clinical practice.
Interpretation:
Delete unsupported claims about the importance of biomarker assessment.
Limitations:
- Add specific examples from the source to enhance clarity.
Conclusion:
Remove unsupported claims about the necessity for advanced techniques.
